FDA approves Roche breast cancer pill, potential top-seller
Published 1 d ago1 sourceEvidence: Reported
The FDA approved Roche's new breast cancer drug, positioning it as a potential top-selling product for the company. The approval provides a new treatment option for certain patients, though the specific patient population and clinical data are not detailed. This marks a significant regulatory milestone for Roche, with commercial implications for the oncology market.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 3 h ago2 sourcesEvidence: Reported
Published 18 h ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported